Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SOLARA | NSE
-8.40
-1.55%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
05/06/2026
534.85
549.00
553.20
532.00
Solara Active Pharma Sciences Limited manufactures produces processes formulates sells imports exports merchandises distributes trades in and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics anthelmintic anti-arrhythmic agent anti-asthmatic anti-hypertensive anti-inflammatory anti-Parkinson anti-viral antibiotic anticoagulant anticonvulsant antidepressant antiemetic antiepileptic antifungal antigout agent antihistamine antihyperlipoproteinemic antimalarial antimycotic antineoplastic detoxifying agent antiprotozoal agent antipsoriatic antipsychotic antitubercular antitussive antiulcerative anxiolytic bile acid analogue calcimimetic agent cardiovascular agent central nervous system agent chronic alcoholism chronic kidney disease dopamine receptor antagonist folate analog hyperkalaemia immunosuppressant lipid regulating agent loop diuretic muscarinic agonist neuromuscular OAB treatment phenylalanine reducer recovery of stroke tardive dyskinesia treatment of glaucoma and hyperphosphatemia tropical anti-infective and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs including contract development and manufacturing analytical services impurity synthesis and regulatory support. In addition the company exports its products. It operates in the Asia Pacific Europe North America South America and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai India.
View LessPositive Momentum
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
29.1%1 month
58.5%3 months
47.7%6 months
43.5%-
-
4.04
1.08
0.43
-21.14
3.52
-
-716.75M
23.18B
244.13M
-
4.64
98.40
3.20
-46.49
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
58.00
Range1M
114.20
Range3M
184.40
Rel. volume
0.28
Price X volume
52.57M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 43.75 | 24.17B | -2.63% | 37.53 | 3.42% |
| Hikal Limited | HIKAL | Drug Manufacturers-Specialty & Generic | 189.62 | 23.38B | -1.19% | 69.03 | 68.84% |
| Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 87.12 | 22.45B | 1.30% | 12.29 | 0.42% |
| Venus Remedies Limited | VENUSREM | Drug Manufacturers-Specialty & Generic | 1633.5 | 21.83B | 4.99% | 16.58 | 8.48% |
| Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 206.84 | 19.06B | -3.02% | 42.22 | 60.54% |
| Windlas Biotech Limited | WINDLAS | Drug Manufacturers-Specialty & Generic | 814.15 | 17.07B | 0.37% | 35.85 | 0.81% |
| Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 1961.6 | 16.69B | 2.04% | 104.15 | 83.75% |
| Amrutanjan Health Care Limited | AMRUTANJAN | Drug Manufacturers-Specialty & Generic | 552.05 | 15.97B | 1.71% | 52.36 | 0.60% |
| SAKAR | SAKAR | Drug Manufacturers-Specialty & Generic | 773.2 | 13.04B | -5.11% | 59.39 | 30.25% |
| Lincoln Pharmaceuticals Ltd | LINCOLN | Drug Manufacturers-Specialty & Generic | 625.55 | 12.53B | 0.97% | 13.55 | 0.18% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 106.44 | 15.68B | 0.92% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 265.15 | 15.54B | -3.12% | 30.54 | 80.30% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 306.65 | 9.91B | -4.99% | 36.36 | 52.08% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 247.99 | 8.85B | -3.28% | 120.49 | 191.28% |
| Madhav Copper Limited | MCL | Copper | 59.6 | 1.64B | -0.28% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 86.92 | 1.26B | -0.36% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 70.46 | 785.54M | -2.29% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 24.6 | 427.05M | -3.42% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.24 | 158.63M | 3.43% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -21.14 | 24.85 | Cheaper |
| Ent. to Revenue | 3.52 | 11.40 | Cheaper |
| PE Ratio | - | 51.36 | - |
| Price to Book | 4.04 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 47.68 | 42.17 | Par |
| Debt to Equity | 1.08 | 0.35 | Expensive |
| Debt to Assets | 0.43 | 0.17 | Expensive |
| Market Cap | 23.18B | 290.82B | Emerging |